GlobeNewswire

VeriTransfer(TM) Unveils the First Known Proof-of-Concept for a Blockchain Enabled Firearms Licence Verification and Ownership Transfer

Dela

Blockchain Enabled Firearms Solution Ensures Instant Verification of Ownership and Safe Transfer While Maintaining Data Privacy

  

 

TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- VeriTransfer(TM) today announced the completion of its Proof-of-Concept ("POC") of the first publicly announced Blockchain enabled solution that decentralizes the process of storing the ownership rights and transfer of firearms.

VeriTransfer(TM) is also pleased to announce that it will donate a percentage of all future revenues or the proceeds from any future sale of the company towards foundations whose mission is to end gun violence and build safer communities.

The Gun Epidemic & The Economic Impact

The United States hosts 4.4% of the world's population, but almost 50% of the 644 million civilian-owned guns globally are located in the U.S. Disturbingly, more American citizens have died as a result of gunshots in the U.S. since 1968 than on the battlefield of all the wars in American history from 1175 to 2015. In addition, the estimated annual cost of fatal and non-fatal gun violence to the U.S. was $229 billion, representing 1.4% of total GDP1.

There have been 154 mass shootings in the United States since January 1st, 2018. This includes 23 school shootings that have occurred as of June 30th, 2018 in the U.S. where someone was either hurt or killed. That averages out to more than one school shooting a week2.                                 

The Potential Bipartisan Solution

VeriTransfer's mission is to help increase public safety, mitigate firearm-related deaths, all while empowering firearm owners to safely manage the ownership of their firearms and maintain complete data privacy. The decentralized and private structure of the VeriTransfer system gives full ownership of firearm data to the licence holder, while empowering law-abiding citizens to reduce the flow of firearms into criminal or suicidal hands.

Mathieu Glaude, CEO of Northern Block, the Toronto-based blockchain product development company is excited about VeriTransfer's potential societal impact. "We see the management of firearms as a perfect use case for blockchain technologies. Empowering individuals and retailers to privately manage their firearms in a decentralized manner is powerful and it presents an optimal solution to the unresolved gun control problem." said Glaude.

"We are incredibly excited to be involved in a real-world use case of blockchain technologies that has the potential to save lives," said Kesem Frank, COO of AION. "This is all achieved while maintaining data privacy and has the potential to eliminate data silos within government agencies."

VeriTransfer is a distributed system that decentralizes the storage of the ownership of firearms. The application makes it easy for any licenced firearm owner/retailer to manage their firearm inventory. Additionally, firearm holders can use VeriTransfer to digitally store a Government-issued licence, if applicable. VeriTransfer makes it simple for users to transfer firearm ownership at point-of-sale (B2B or B2C) or between licence holders (C2C) by scanning a QR code of the purchaser's licence using their mobile device. Additionally, firearm retailers can use VeriTransfer to perform licence eligibility checks prior to transferring firearm ownership to another person (e.g., selling a restricted firearm).

VeriTransfer is not a gun registry, it's a decentralized application that gives full ownership of firearm data to the licence owner. Firearm owners can be confident that their firearm data remains private and in their control at all times. Details about someone's identity, firearm licence (if applicable), and firearm ownership remain fully confidential and can only be accessed by external parties if consent is provided.

With blockchain technologies, the VeriTransfer decentralized application (dApp) uses permissioned smart contracts for users to access data from the blockchain. Firearms are turned into unique digital tokens, similar to the ERC-721 non-fungible token standard developed for Ethereum. These unique tokens are tied to engraved serial numbers or RFID-chipped firearms. Firearm ownership can be transferred between licence holders by sending these tokens electronically between the blockchain addresses of the licence holders. There's no need for users to acquire tokens, since they are automatically created through the system every time a firearm is added to the network.

Technology Overview

AION Blockchain

AION is an all-in-one blockchain network that enables hybrid architectures, scalability and interoperability for solutions built on top of it. AION allows building interoperable permissioned blockchains that has the ability to scale to an enterprise level.

Key Smart Contracts

Many functions of VeriTransfer (TM) rely on smart contracts within AION. A smart contract is a collection of code and data that resides on a specific blockchain address. They can facilitate, verify and enforce access to blockchain data between different users. Smart contracts can be described as a specific data slot on a blockchain that can be queried and changed by calling its functions. 

In VeriTransfer (TM), a firearm licence holder's data is managed through the following smart contracts: 

1. Licensing Smart Contract. Anytime a firearm licence is issued to an individual, a transaction is sent to VeriTransfer's permissioned blockchain. This smart contract records the fact that a person has a licence and stores the hashed validation of this fact to the permissioned blockchain. This allows for immutable track records of firearm holders to be kept on the blockchain.

2. Firearms Smart Contract. This maintains the record of gun ownership represented by a digital token within the contract and associates it with a specific individual. Retailers and firearms holders can pass the ownership from one to another, and the smart contract will facilitate the transfer of the digital token between users that are registered on a blockchain and have a blockchain address.

These two smart contracts interact with one another. Every new firearm registered in the system creates a new unique token that can be associated with a dealer's / individual's blockchain address.

Conclusion

The completion of the VeriTransfer (TM) Proof-of Concept is significant, as this process and key technology can be replicated in a bespoke manner for the US market, while dually maintaining data privacy without violating the Second Amendment of the United States Constitution. VeriTransfer is currently in discussions with various parties in order to commence a Pilot Project in Canada and/or the United States with selected firearms dealers and government agencies.  You can find a link to our Whitepaper and video demo of the application here:  Veritransfer.io

About VeriTransfer (TM)

VeriTransfer (TM), is the first known Blockchain enabled distributed system that decentralizes the process of the storage of the ownership rights, and transfer of firearms.

Key Contacts

Mark Lawson
VeriTransfer(TM) 
T: +1 647 256 1986 
mark@veritransfer.io

Mathieu Glaude
CEO, Northern Block Inc.
T: +1 647 991 8863
mathieu@northernblock.ca

Kesem Frank
COO, AION
T: +1 647 970 3736
kesem@mavennet.com

References:

  1. Michelle Singletary, The Washington Post, February 22, 2018; Mother Jones Report.
  2. Gun Violence Archive, 2018.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/830e7a9e-b315-46f6-8a35-a0b46d84dc81




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: VeriTransfer via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum